Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

In Memoriam: Paul Alphonso Godley, MD, PhD, MPP.

Brawley OW.

J Natl Cancer Inst. 2019 Jun 21. pii: djz087. doi: 10.1093/jnci/djz087. [Epub ahead of print] No abstract available.

PMID:
31225590
2.

Racial Inequality in Prostate Cancer Outcomes-Socioeconomics, Not Biology.

Paller CJ, Wang L, Brawley OW.

JAMA Oncol. 2019 May 23. doi: 10.1001/jamaoncol.2019.0812. [Epub ahead of print] No abstract available.

PMID:
31120499
3.

Perceptions of Patients With Breast and Colon Cancer of the Management of Cancer-Related Pain, Fatigue, and Emotional Distress in Community Oncology.

Smith TG, Troeschel AN, Castro KM, Arora NK, Stein K, Lipscomb J, Brawley OW, McCabe RM, Clauser SB, Ward E.

J Clin Oncol. 2019 Jul 1;37(19):1666-1676. doi: 10.1200/JCO.18.01579. Epub 2019 May 17.

PMID:
31100037
4.

The American Cancer Society 2035 challenge goal on cancer mortality reduction.

Ma J, Jemal A, Fedewa SA, Islami F, Lichtenfeld JL, Wender RC, Cullen KJ, Brawley OW.

CA Cancer J Clin. 2019 May 8. doi: 10.3322/caac.21564. [Epub ahead of print]

5.

Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.

Polite BN, Gluck AR, Brawley OW.

JAMA. 2019 Apr 8. doi: 10.1001/jama.2019.4266. [Epub ahead of print] No abstract available.

PMID:
30958509
6.

The history of cancer screening.

Jatoi I, Anderson WF, Miller AB, Brawley OW.

Curr Probl Surg. 2019 Apr;56(4):138-163. doi: 10.1067/j.cpsurg.2018.12.006. Epub 2019 Jan 14. No abstract available.

PMID:
30922446
7.

Minimizing the burden of cancer in the United States: Goals for a high-performing health care system.

Yabroff KR, Gansler T, Wender RC, Cullen KJ, Brawley OW.

CA Cancer J Clin. 2019 May;69(3):166-183. doi: 10.3322/caac.21556. Epub 2019 Feb 20.

8.

A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control.

Wender RC, Brawley OW, Fedewa SA, Gansler T, Smith RA.

CA Cancer J Clin. 2019 Jan;69(1):50-79. doi: 10.3322/caac.21550. Epub 2018 Nov 19.

9.

Comparison of Insurance Status and Diagnosis Stage Among Patients With Newly Diagnosed Cancer Before vs After Implementation of the Patient Protection and Affordable Care Act.

Han X, Yabroff KR, Ward E, Brawley OW, Jemal A.

JAMA Oncol. 2018 Dec 1;4(12):1713-1720. doi: 10.1001/jamaoncol.2018.3467.

PMID:
30422152
10.

Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy.

Alfano CM, Leach CR, Smith TG, Miller KD, Alcaraz KI, Cannady RS, Wender RC, Brawley OW.

CA Cancer J Clin. 2019 Jan;69(1):35-49. doi: 10.3322/caac.21548. Epub 2018 Oct 30.

11.

Toward the control of cancer.

Brawley OW, Gansler T, Wender RC.

CA Cancer J Clin. 2018 Sep;68(5):327-328. doi: 10.3322/caac.21461. Epub 2018 Jul 10. No abstract available.

12.

A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors.

Gapstur SM, Drope JM, Jacobs EJ, Teras LR, McCullough ML, Douglas CE, Patel AV, Wender RC, Brawley OW.

CA Cancer J Clin. 2018 Nov;68(6):446-470. doi: 10.3322/caac.21496. Epub 2018 Oct 10. Erratum in: CA Cancer J Clin. 2019 Mar;69(2):158.

13.

An assessment of progress in cancer control.

Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW.

CA Cancer J Clin. 2018 Sep;68(5):329-339. doi: 10.3322/caac.21460. Epub 2018 Jul 10.

14.

Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors.

Welch HG, Brawley OW.

Ann Intern Med. 2018 Jul 17;169(2):134-135. doi: 10.7326/L18-0146. No abstract available.

PMID:
30014102
15.

Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA.

CA Cancer J Clin. 2018 Jul;68(4):250-281. doi: 10.3322/caac.21457. Epub 2018 May 30.

16.

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30. Review.

17.

Prostate cancer screening: And the pendulum swings.

Brawley OW.

Cancer. 2018 Jul 15;124(14):2890-2892. doi: 10.1002/cncr.31380. Epub 2018 May 3. No abstract available.

18.

Some Thoughts on Exposure to the World Trade Center Wreckage and Cancer.

Brawley OW.

JAMA Oncol. 2018 Jun 1;4(6):775-776. doi: 10.1001/jamaoncol.2018.0498. No abstract available.

PMID:
29710327
19.

Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

Fedewa SA, Gansler T, Smith R, Sauer AG, Wender R, Brawley OW, Jemal A.

Ann Fam Med. 2018 Mar;16(2):139-144. doi: 10.1370/afm.2200.

20.

Low-dose CT for lung cancer screening.

Bach PB, Brawley OW, Silvestri GA.

Lancet Oncol. 2018 Mar;19(3):e133-e134. doi: 10.1016/S1470-2045(18)30117-7. No abstract available.

PMID:
29508757
21.

First international TNBC conference meeting report.

Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R.

Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.

22.

Re: Fine Particulate Matter and Total Mortality in Cancer Prevention Study Cohort Reanalysis.

Gapstur SM, Brawley OW.

Dose Response. 2017 Dec 22;15(4):1559325817749412. doi: 10.1177/1559325817749412. eCollection 2017 Oct-Dec. No abstract available.

23.

Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors.

Welch HG, Brawley OW.

Ann Intern Med. 2018 Jan 16;168(2):143-144. doi: 10.7326/M17-2792. Epub 2018 Jan 2. No abstract available.

PMID:
29297002
24.

Editorial Comment.

Brawley OW.

J Urol. 2018 Mar;199(3):681-682. doi: 10.1016/j.juro.2017.09.171. Epub 2017 Dec 20. No abstract available.

PMID:
29272711
25.

An Appreciation of the U.S. Preventive Services Task Force.

Brawley OW.

Am J Prev Med. 2018 Jan;54(1):151-152. doi: 10.1016/j.amepre.2017.10.013. No abstract available.

PMID:
29254552
26.

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A.

CA Cancer J Clin. 2018 Jan;68(1):31-54. doi: 10.3322/caac.21440. Epub 2017 Nov 21.

27.

Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.

Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A.

Gastroenterology. 2018 Mar;154(4):906-915.e7. doi: 10.1053/j.gastro.2017.11.005. Epub 2017 Nov 14.

28.

On assessing the effect of breast cancer screening schemes.

Brawley OW.

Cancer. 2017 Oct 1;123(19):3656-3659. doi: 10.1002/cncr.30840. Epub 2017 Aug 21. No abstract available.

29.

The role of government and regulation in cancer prevention.

Brawley OW.

Lancet Oncol. 2017 Aug;18(8):e483-e493. doi: 10.1016/S1470-2045(17)30374-1. Epub 2017 Jul 26. Review.

PMID:
28759387
30.

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

Cancer Res. 2017 Sep 1;77(17):4548-4555. doi: 10.1158/0008-5472.CAN-17-0623. Epub 2017 Jul 24. No abstract available.

31.

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

CA Cancer J Clin. 2017 Sep;67(5):353-361. doi: 10.3322/caac.21404. Epub 2017 Jul 24. No abstract available.

32.

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

J Clin Oncol. 2017 Sep 10;35(26):3075-3082. doi: 10.1200/JCO.2017.73.6546. Epub 2017 Jul 24. No abstract available.

PMID:
28737975
33.

American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce.

Winkfield KM, Flowers CR, Patel JD, Rodriguez G, Robinson P, Agarwal A, Pierce L, Brawley OW, Mitchell EP, Head-Smith KT, Wollins DS, Hayes DF.

J Clin Oncol. 2017 Aug 1;35(22):2576-2579. doi: 10.1200/JCO.2017.73.1372. Epub 2017 May 1.

PMID:
28459634
34.

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.

35.

Accepting the Existence of Breast Cancer Overdiagnosis.

Brawley OW.

Ann Intern Med. 2017 Mar 7;166(5):364-365. doi: 10.7326/M16-2850. Epub 2017 Jan 10. No abstract available.

PMID:
28114628
36.

Civil society's role in efforts to control women's cancers.

Brawley OW, Cowal SG.

Lancet. 2017 Feb 25;389(10071):775-776. doi: 10.1016/S0140-6736(16)31799-8. Epub 2016 Nov 1. No abstract available.

PMID:
27814966
37.

Insurance status, health equity, and the cancer care continuum.

Halpern MT, Brawley OW.

Cancer. 2016 Oct 15;122(20):3106-3109. doi: 10.1002/cncr.30158. Epub 2016 Aug 8. No abstract available.

38.

Evolving Recommendations on Prostate Cancer Screening.

Brawley OW, Thompson IM Jr, Grönberg H.

Am Soc Clin Oncol Educ Book. 2016;35:e80-7. doi: 10.14694/EDBK_157413.

39.

The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections.

Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW.

CA Cancer J Clin. 2016 Sep;66(5):359-69. doi: 10.3322/caac.21348. Epub 2016 May 13.

40.

Some thoughts on health surveillance data, race, and population categorization.

Brawley OW.

CA Cancer J Clin. 2016 May;66(3):179-81. doi: 10.3322/caac.21346. Epub 2016 Mar 21. No abstract available.

41.

The cancer registry as a cancer-control tool.

Brawley OW.

Cancer. 2016 May 1;122(9):1343-5. doi: 10.1002/cncr.29968. Epub 2016 Mar 9. No abstract available.

42.

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC.

CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114. doi: 10.3322/caac.21336. Epub 2016 Jan 21. Review.

43.

The Meaning of Race in Prostate Cancer Treatment.

Brawley OW.

JAMA Oncol. 2016 Jan;2(1):93-4. doi: 10.1001/jamaoncol.2015.3615. No abstract available.

PMID:
26502032
44.

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society.

JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

45.

Cancer statistics: Breast cancer in situ.

Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A, Kohler B, Brawley OW, Gansler T.

CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95. doi: 10.3322/caac.21321. Epub 2015 Oct 2.

46.

How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?

Fedewa SA, Ma J, Sauer AG, Siegel RL, Smith RA, Wender RC, Doroshenk MK, Brawley OW, Ward EM, Jemal A.

Cancer. 2015 Dec 1;121(23):4258-65. doi: 10.1002/cncr.29659. Epub 2015 Aug 26.

47.

Editorial Comment.

Brawley OW.

Urology. 2015 Sep;86(3):504. doi: 10.1016/j.urology.2015.04.064. Epub 2015 Aug 15. No abstract available.

PMID:
26282018
48.

Advancing a Quality-of-Life Agenda in Cancer Advocacy: Beyond the War Metaphor.

Parikh RB, Kirch RA, Brawley OW.

JAMA Oncol. 2015 Jul;1(4):423-4. doi: 10.1001/jamaoncol.2015.0925. No abstract available.

PMID:
26181244
49.

CDC Grand Rounds: the future of cancer screening.

Thomas CC, Richards TB, Plescia M, Wong FL, Ballard R, Levin TR, Calonge BN, Brawley OW, Iskander J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Apr 3;64(12):324-7.

50.

Ovarian cancer prevention: Time for primetime?

Brawley OW.

Cancer. 2015 Jul 1;121(13):2121-3. doi: 10.1002/cncr.29347. Epub 2015 Mar 27. No abstract available.

Supplemental Content

Loading ...
Support Center